134 related articles for article (PubMed ID: 20878062)
1. Mechanisms behind COX-1 and COX-2 inhibition of tumor growth in vivo.
Axelsson H; Lönnroth C; Andersson M; Lundholm K
Int J Oncol; 2010 Nov; 37(5):1143-52. PubMed ID: 20878062
[TBL] [Abstract][Full Text] [Related]
2. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibition in early onset of tumor growth and related angiogenesis evaluated in EP1 and EP3 knockout tumor-bearing mice.
Axelsson H; Lönnroth C; Wang W; Svanberg E; Lundholm K
Angiogenesis; 2005; 8(4):339-48. PubMed ID: 16400521
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin and telomerase activity in tumor growth retardation.
Lönnroth C; Andersson M; Lundholm K
Int J Oncol; 2001 May; 18(5):929-37. PubMed ID: 11295037
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo.
Eli Y; Przedecki F; Levin G; Kariv N; Raz A
Biochem Pharmacol; 2001 Mar; 61(5):565-71. PubMed ID: 11239499
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
7. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene.
Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS
Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis.
Setia S; Sanyal SN
Pharmacol Rep; 2012; 64(3):615-24. PubMed ID: 22814015
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
Bourn J; Cekanova M
Drug Des Devel Ther; 2018; 12():1727-1742. PubMed ID: 29942116
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis.
Feitoza CQ; Gonçalves GM; Semedo P; Cenedeze MA; Pinheiro HS; Beraldo FC; dos Santos OF; Teixeira Vde P; dos Reis MA; Mazzali M; Pacheco-Silva A; Câmara NO
Mol Med; 2008; 14(11-12):724-30. PubMed ID: 18769637
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine.
Kajanne R; Leppä S; Luukkainen P; Ustinov J; Thiel A; Ristimäki A; Miettinen PJ
Pediatr Res; 2007 Nov; 62(5):570-5. PubMed ID: 17805209
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
19. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
Chiou SK; Hodges A; Hoa N
J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
[TBL] [Abstract][Full Text] [Related]
20. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
